Purchase Order 75N92B19P00048

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100.00 on August 23, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order was completed by August 22, 2019. Pricing was firm fixed price for commercial genomic analysis instruments, consumables, or reagents—10X Genomics' core product portfolio in single-cell and spatial transcriptomics platforms supplied to federal research agencies.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,285.50 on September 10, 2019, with completion by September 9, 2020. No set-aside applied. Work is performed at Bethesda, Maryland. The order is priced on a firm fixed price basis for genomic analysis instruments, consumables, or reagents consistent with the vendor's product portfolio of single-cell and spatial transcriptomics platforms and associated kits.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $23,045.50 on November 12, 2019, with completion by November 11, 2020. No set-aside was used. Performance occurs at Bethesda, Maryland. The order is priced on a firm fixed price basis. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies; this order procures genomic analysis instruments or...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to 10X Genomics, Inc. valued at $21,581 with an award date of December 12, 2017. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments and consumables under a firm fixed price arrangement with a period of performance from December 12, 2017 through December 11, 2018.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,290.50 on August 14, 2018, with completion on August 13, 2019. No set-aside was used. Performance occurred in Bethesda, Maryland. The order was for commercial genomic analysis instruments, consumables, or reagents supplied on a firm fixed-price basis by the manufacturer of single-cell and spatial transcriptomics platforms.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $20,838.50 on July 8, 2019, with completion scheduled for July 22, 2019. No small business set-aside was used. Place of performance is Bethesda, Maryland. The order is firm fixed price for commercial genomics reagents and consumables supplied to the federal research agency, typical of 10X Genomics' NIH-focused business model in single-cell and spatial transcriptomics...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,067.00 on June 4, 2019, with completion on June 18, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order procures genomic analysis consumables and reagents under firm fixed price terms.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $24,896.00 on May 7, 2019, with an ultimate completion date of May 31, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. Specific requirements are not detailed in the source.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 12, 2019, for a Chromium System to enable genomic research including phase-resolved structural variants analysis. Performance is located in Bethesda, Maryland, with a period of performance from September 12, 2019 through September 11, 2020. The purchase order is firm fixed price with no set-aside designation.</p>